Page last updated: 2024-10-31

modafinil and Kidney Diseases

modafinil has been researched along with Kidney Diseases in 2 studies

Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.

Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.

Research Excerpts

ExcerptRelevanceReference
"Modafinil is a unique wake-promoting agent for oral administration."2.42Clinical pharmacokinetic profile of modafinil. ( Hellriegel, ET; Robertson, P, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Robertson, P1
Hellriegel, ET1
Jefferson, HJ1
Jayne, DR1

Reviews

1 review available for modafinil and Kidney Diseases

ArticleYear
Clinical pharmacokinetic profile of modafinil.
    Clinical pharmacokinetics, 2003, Volume: 42, Issue:2

    Topics: Aged; Benzhydryl Compounds; Biological Availability; Central Nervous System Stimulants; Drug Interac

2003

Other Studies

1 other study available for modafinil and Kidney Diseases

ArticleYear
Peripheral vasculopathy and nephropathy in association with phentermine.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:7

    Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Female; Humans; Kidney Diseases; Middle Age

1999